Top ▲

GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

The IUPHAR Guide to IMMUNOPHARMACOLOGY ligand list

Click here for help
GtoImmuPdb ligands only: Low molecular weight, non-peptidic, biogenic compounds produced by life processes (normally endogenous and of animal origin, including hormones and neurotransmitters) and their close analogues.
Download as CSV

A   B   C   D   H   L   M   P   R   S   T  

Ligand name ID Synonyms
A Back to top
(-)-adrenaline Approved drug PDB Ligand Immunopharmacology Ligand 479 adrenalin, Auvi-Q®, Epipen®, l-adrenaline, L-epinephrine, levoepinephrine
aspirin-triggered resolvin D1 Immunopharmacology Ligand 6239 AT-Resolvin D1, AT-RvD1
 
B Back to top
betamethasone Approved drug Immunopharmacology Ligand 7061 SCH-4831
butyric acid PDB Ligand Immunopharmacology Ligand 1059 butanoic acid, butyrate, C4
 
C Back to top
2'3'-cGAMP PDB Ligand Immunopharmacology Ligand 9207 cyclic [G(2',5')pA(3',5')p], cyclic GMP-AMP, Cyclic guanosine monophosphate-adenosine monophosphate
corticosterone PDB Ligand Immunopharmacology Ligand 2869
cortisol Approved drug PDB Ligand Immunopharmacology Ligand 2868 Acticort®, Efmody®, Plenadren®
 
D Back to top
desoximetasone Approved drug Immunopharmacology Ligand 7067 A-41-304, HOE-304, R-2113, Topicort®
dopamine Approved drug PDB Ligand Immunopharmacology Ligand 940 3-hydroxytyramine
dyphylline Approved drug Immunopharmacology Ligand 7070 Dilor®
 
H Back to top
histamine PDB Ligand Immunopharmacology Ligand 1204
 
L Back to top
loteprednol etabonate Approved drug Immunopharmacology Ligand 7085 HGP-1, Inveltys®, Lotemax®, P-5604
LTB4 PDB Ligand Immunopharmacology Ligand 2487 leukotriene B4
LXB4 Immunopharmacology Ligand 5216 lipoxin B4
 
M Back to top
medrysone Approved drug Immunopharmacology Ligand 7086 U-8471
melatonin Approved drug PDB Ligand Immunopharmacology Ligand 224 MLT, Circadin®
methylprednisolone Approved drug Immunopharmacology Ligand 7088 Medrol®, U-67590A
 
P Back to top
PAF PDB Ligand Immunopharmacology Ligand 1831 PAF (C16), PAF C-16, platelet activating factor
PGE2 Approved drug PDB Ligand Immunopharmacology Ligand 1883 Cervidil®, minprositin E2, minprostin E2, Propess®, prostaglandin E2
PGF2α PDB Ligand Immunopharmacology Ligand 1884 prostaglandin F2α
 
R Back to top
resolvin D1 Immunopharmacology Ligand 3934 RvD1, 7S,8R,17S‐trihydroxy‐4Z,9E,11E,13Z,15E,19Z‐docosahexaenoic acid
resolvin D2 Immunopharmacology Ligand 5417
resolvin E1 Immunopharmacology Ligand 3333 RvE1, 5S,12R,18R‐trihydroxy‐6Z,8E,10E,14Z,16E‐eicosapentaenoic acid
rimexolone Approved drug Immunopharmacology Ligand 7099 ORG-6216, Vexol®
RvD1-ME Immunopharmacology Ligand 5555 RvD1-methyl ester
 
S Back to top
sapropterin Approved drug PDB Ligand Immunopharmacology Ligand 5276 Kuvan®, sapropterin dihydrochloride, SUN-0588, T-1401, tetrahydrobiopterin (THB)
18S-resolvin E1 Immunopharmacology Ligand 5106 18S-RvE1
 
T Back to top
tauroursodeoxycholic acid Approved drug PDB Ligand Immunopharmacology Ligand 4746 TUDA, Relyvrio® (sodium phenylbutyrate + taurursodiol), tauroursodeoxycholate, taurursodiol, TUDCA, UR 906, ursodoxicoltaurine (INN)